CNS Therapeutics Xchange 2022 – US West Coast
SYNAPCELL SPONSORS THE CNS XCHANGE 2022 HubXchange’s West Coast CNS…
SynapCell’s experts hit the West Coast road ! [June 2022]
FINALLY BACK ON THE ROAD… Taking advantage of two major…
EILAT XVI CONFERENCE ON NEW ANTIEPILEPTIC DRUGS & DEVICES
See you in madrid ! SynapCell will attend the 16th…
ADPD 2022: EEG Biomarkers used to evaluate Anti-Dyskinetic effect of drugs in Parkinson’s Disease
ADDRESSING LDOPA INDUCED DYSKINESIA IN PARKINSON'S: POSTER COMMUNICATION [Abstract] Thanks…
AES 2021: Partnership with OVID Threapeutics in Epilepsy
The American Epilepsy Society Annual Meeting is taking place in…
CNS Therapeutics Xchange 2021
https://synapcell.com/wp-content/uploads/2021/11/HubXchange-CNS-Therapeutics_Preclinical-1.mp4 PROUD TO BE SPONSORING This year HubxChange Europe will…
Society for Neuroscience 2021
Celebrating 50 years of the Society for Neuroscience The Society…
IPEG 2021. A Virtual Event
INTERNATIONAL PHARMACO EEG SOCIETY – IPEG2021 SynapCell is proud to…
BioJapan 2021 & more!
BIOTECH WEEK IN JAPAN SynapCell is proud to participate to…
Webinar: Parkinson’s disease
SPOT THE SIGNS Parkinson’s disease represents a major burden affecting over…